Craig Ballaron - Net Worth and Insider Trading

Craig Ballaron Net Worth

The estimated net worth of Craig Ballaron is at least $85,600 dollars as of 2024-05-25. Craig Ballaron is the Director of Verrica Pharmaceuticals Inc and owns about 10,000 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $85,600. Details can be seen in Craig Ballaron's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Craig Ballaron has not made any transactions after 2020-08-25 and currently still holds the listed stock(s).

Transaction Summary of Craig Ballaron

To

Craig Ballaron Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Craig Ballaron owns 1 companies in total, including Verrica Pharmaceuticals Inc (VRCA) .

Click here to see the complete history of Craig Ballaron’s form 4 insider trades.

Insider Ownership Summary of Craig Ballaron

Ticker Comapny Transaction Date Type of Owner
VRCA Verrica Pharmaceuticals Inc 2020-08-25 director

Craig Ballaron Latest Holdings Summary

Craig Ballaron currently owns a total of 1 stock. Craig Ballaron owns 10,000 shares of Verrica Pharmaceuticals Inc (VRCA) as of August 25, 2020, with a value of $85,600.

Latest Holdings of Craig Ballaron

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VRCA Verrica Pharmaceuticals Inc 2020-08-25 10,000 8.56 85,600

Holding Weightings of Craig Ballaron


Craig Ballaron Form 4 Trading Tracker

According to the SEC Form 4 filings, Craig Ballaron has made a total of 1 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Verrica Pharmaceuticals Inc is the acquisition of 10,000 shares on August 25, 2020, which cost Craig Ballaron around $88,800.

Insider Trading History of Craig Ballaron

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Craig Ballaron Trading Performance

GuruFocus tracks the stock performance after each of Craig Ballaron's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig Ballaron is 7.51%. GuruFocus also compares Craig Ballaron's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig Ballaron within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Craig Ballaron's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Craig Ballaron

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.28
Relative Return to S&P 500(%) -3.06

Craig Ballaron Ownership Network

Ownership Network List of Craig Ballaron

No Data

Ownership Network Relation of Craig Ballaron


Craig Ballaron Owned Company Details

What does Verrica Pharmaceuticals Inc do?

Who are the key executives at Verrica Pharmaceuticals Inc?

Craig Ballaron is the director of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , director & President and CEO Ted White , and Chief Commercial Officer Joe Bonaccorso .

Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary

Over the past 18 months, Craig Ballaron made no insider transaction in Verrica Pharmaceuticals Inc (VRCA). Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net purchase of 2,060,199 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 84,376 shares made by Ted White , and a net sale of 71,108 shares made by Joe Bonaccorso .

In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 288,608 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,971,591 shares.

Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Verrica Pharmaceuticals Inc Insider Transactions

No Available Data

Craig Ballaron Mailing Address

Above is the net worth, insider trading, and ownership report for Craig Ballaron. You might contact Craig Ballaron via mailing address: C/o Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester Pa 19380.

Discussions on Craig Ballaron

No discussions yet.